UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Telaprevir for Retreatment of HCV Infection

The New England journal of medicine, 2011-06, Vol.364 (25), p.2417-2428

2011

Volltextzugriff (PDF)

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2014-08, Vol.384 (9941), p.403-413

2014

Volltextzugriff (PDF)

Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older

PloS one, 2019-01, Vol.14 (1), p.e0208506

2019

Volltextzugriff (PDF)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

Journal of hepatology, 2016-07, Vol.65 (1), p.17-25

2016

Volltextzugriff (PDF)

Second generation direct-acting antivirals – Do we expect major improvements?

Journal of hepatology, 2016-10, Vol.65 (1), p.S130-S142

2016

Volltextzugriff (PDF)

Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1

The New England journal of medicine, 2014-01, Vol.370 (3), p.222-232

2014

Volltextzugriff (PDF)

Interferons at age 50: past, current and future impact on biomedicine

Nature reviews. Drug discovery, 2007-12, Vol.6 (12), p.975-990

2007

Volltextzugriff (PDF)

Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention

BMC medicine, 2019-04, Vol.17 (1), p.71-71, Article 71

2019

Volltextzugriff (PDF)

Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement

Journal of hepatology, 2012-12, Vol.57 (6), p.1379-1390

2012

Volltextzugriff (PDF)

Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo

PLoS pathogens, 2016-08, Vol.12 (8), p.e1005788-e1005788

2016

Volltextzugriff (PDF)

Results from a retrospective case finding and re-engagement exercise for people previously diagnosed with hepatitis C virus to increase uptake of directly acting antiviral treatment

BMC public health, 2024-09, Vol.24 (1), p.1-14, Article 2427

2024

Volltextzugriff (PDF)

Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection

Journal of hepatology, 2015-03, Vol.62 (3), p.533-540

2015

Volltextzugriff (PDF)

Pharmacology and therapeutic potential of interferons

Pharmacology & therapeutics (Oxford), 2012-07, Vol.135 (1), p.44-53

2012

Volltextzugriff (PDF)

Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost

Journal of translational medicine, 2022-01, Vol.20 (1), p.2-2, Article 2

2022

Volltextzugriff (PDF)

Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure

Nature communications, 2021-10, Vol.12 (1), p.6105-11, Article 6105

2021

Volltextzugriff (PDF)

The way forward in HCV treatment - finding the right path

Nature reviews. Drug discovery, 2007-12, Vol.6 (12), p.991-1000

2007

Volltextzugriff (PDF)

Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection

Journal of gastroenterology, 2019-08, Vol.54 (8), p.752-761

2019

Volltextzugriff (PDF)

HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocol

BMC public health, 2023-12, Vol.23 (1), p.2529-2529, Article 2529

2023

Volltextzugriff (PDF)

Liver-related aspects of gene therapy for haemophilia: Call to action for collaboration between haematologists and hepatologists

Journal of hepatology, 2023-03, Vol.78 (3), p.467-470

2023

Volltextzugriff (PDF)

Liver-related aspects of gene therapy for hemophilia: need for collaborations with hepatologists

Journal of thrombosis and haemostasis, 2023-02, Vol.21 (2), p.200-203

2023

Volltextzugriff (PDF)

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

PloS one, 2020-04, Vol.15 (4), p.e0230893-e0230893

2020

Volltextzugriff (PDF)

Clinical Dilemmas in Viral Liver Disease

2nd edition., 2020

Volltextzugriff (PDF)

SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants

Journal of medical virology, 2017-09, Vol.89 (9), p.1620-1628

2017

Volltextzugriff (PDF)

Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression

Journal of Virology, 2005-05, Vol.79 (9), p.5414-5420

2005

Volltextzugriff (PDF)

1 – 25 von 857

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(724)
Mit Volltextzugriff
(798)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(856)
Japanisch
(78)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(605)
Technology
(283)
Life Sciences & Biomedicine
(278)
Computer Science
(274)
Computer Science, Theory & Methods
(272)
Humans
(249)
Computer Science, Interdisciplinary Applications
(149)
Male
(134)
Female
(130)
Hepatitis C
(110)
Adult
(106)
Middle Aged
(103)
Gastroenterology & Hepatology
(95)
Biological And Medical Sciences
(74)
Antiviral Agents - Therapeutic Use
(71)
Genetic Algorithm
(68)
Hepatitis
(67)
Medical Sciences
(65)
Hepatitis C Virus
(64)
Aged
(63)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Telaprevir for Retreatment of HCV Infection

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study

Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

Second generation direct-acting antivirals – Do we expect major improvements?

Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1

Interferons at age 50: past, current and future impact on biomedicine

Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention

Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement

Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo

Results from a retrospective case finding and re-engagement exercise for people previously diagnosed with hepatitis C virus to increase uptake of directly acting antiviral treatment

Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection

Pharmacology and therapeutic potential of interferons

Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost

Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure

The way forward in HCV treatment - finding the right path

Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection

HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocol

Liver-related aspects of gene therapy for haemophilia: Call to action for collaboration between haematologists and hepatologists

Liver-related aspects of gene therapy for hemophilia: need for collaborations with hepatologists

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

Clinical Dilemmas in Viral Liver Disease

SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants

Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression

Suchergebnisse filtern